|Articles|August 12, 2020
- Pharmaceutical Executive-08-01-2020
- Volume 40
- Issue 8
Pharmaceutical Executive, August 2020 Issue (PDF)
Click here for a link to open the Pharmaceutical Executive August 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec’s 19th Annual Industry Auditabout 6 years ago
AI and Social Listening: Myths vs. Factsabout 6 years ago
A Good Time to ‘Revamp’ Sales and Marketingabout 6 years ago
Tapping Compliance Data to Drive Successabout 6 years ago
Pricing, Innovation, and a Pound of Fleshabout 6 years ago
Strategic Realignment for a Better Future 1about 6 years ago
Tackling a ‘Genius Virus’about 6 years ago
Leaders Need to Hit Pricing Issue Head-Onabout 6 years ago
The New Data Dynamic: How COVID-19 has Upended Modelabout 6 years ago
Making Strides in Pharma Gender ParityAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5